Fredun Pharmaceuticals secures tender from TNMSC for supply of Generic Pharma Products worth Rs. 150-180 Million

Fredun Pharmaceuticals Limited (BSE: 539730), a leading provider of pharmaceuticals and innovative healthcare solutions for Pharmaceutical & veterinary applications, is pleased to announce that it has been awarded a significant tender by the Tamil Nadu Medical Services Corporation (TNMSC) for the supply of generic medicines. The total value of the tender ranges between Rs. 150 million and Rs. 180 million.

The supply of these goods is set to commence within the first quarter of FY26 and will extend over a period of 14 months. This development underlines Fredun Pharma's commitment to providing high-quality and affordable healthcare solutions to the community.

The products will be part of the Fredun Gx brand, which is known for its dedication to excellence and reliability. This tender award from TNMSC not only reinforces our position in the market but also aligns with our mission to enhance access to essential medications for all.

Commenting on the Development, Mr. Fredun Medhora, Managing Director, said: "We are thrilled to have been awarded this tender by TNMSC. This achievement reflects our ongoing efforts to deliver quality healthcare solutions and our commitment to serving the needs of the public health sector. We look forward to a successful collaboration with TNMSC and to making a positive impact on the healthcare landscape in Tamil Nadu."

Shares of Fredun Pharmaceuticals Ltd was last trading in BSE at Rs. 645.10 as compared to the previous close of Rs. 665.15. The total number of shares traded during the day was 7379 in over 279 trades.

The stock hit an intraday high of Rs. 684.00 and intraday low of 635.05. The net turnover during the day was Rs. 4793171.00.

Source : Equity Bulls

Keywords

FredunPharmaceuticals INE194R01017 Tender OrderWin TNMSC